Healthcare provider profile · identity verified

John Rs Weber, MD

Family Practice · OSHKOSH, WI · NPI 1467569426

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	151
Losartan Potassium	Losartan Potassium	360	95
Omeprazole	Omeprazole	328	85
Amlodipine Besylate	Amlodipine Besylate	296	78
Metoprolol Succinate	Metoprolol Succinate	279	64
Hydrochlorothiazide	Hydrochlorothiazide	270	70
Lisinopril	Lisinopril	270	69
Rosuvastatin Calcium	Rosuvastatin Calcium	266	75
Levothyroxine Sodium	Levothyroxine Sodium	260	63
Metformin Hcl Er	Metformin Hcl	240	61
Pantoprazole Sodium	Pantoprazole Sodium	237	54
Allopurinol	Allopurinol	199	53
Tamsulosin Hcl	Tamsulosin Hcl	186	49
Furosemide	Furosemide	175	50
Glipizide Er	Glipizide	144	39
Simvastatin	Simvastatin	140	34
Atenolol	Atenolol	138	32
Pravastatin Sodium	Pravastatin Sodium	136	35
Famotidine	Famotidine	133	40
Warfarin Sodium	Warfarin Sodium	133	32
Gabapentin	Gabapentin	129	35
Sertraline Hcl	Sertraline Hcl	122	30
Metoprolol Tartrate	Metoprolol Tartrate	119	35
Eliquis	Apixaban	115	24
Albuterol Sulfate Hfa	Albuterol Sulfate	110	51
Metformin Hcl	Metformin Hcl	110	28
Potassium Chloride	Potassium Chloride	93	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	19
Fluticasone Propionate	Fluticasone Propionate	84	40
Escitalopram Oxalate	Escitalopram Oxalate	82	22
Finasteride	Finasteride	80	20
Meloxicam	Meloxicam	77	26
Tizanidine Hcl	Tizanidine Hcl	77	23
Ezetimibe	Ezetimibe	74	21
Alendronate Sodium	Alendronate Sodium	72	14
Triamcinolone Acetonide	Triamcinolone Acetonide	69	34
Glimepiride	Glimepiride	65	17
Trazodone Hcl	Trazodone Hcl	65	15
Jardiance	Empagliflozin	64	19
Montelukast Sodium	Montelukast Sodium	64	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	17
Amitriptyline Hcl	Amitriptyline Hcl	61	15
Pioglitazone Hcl	Pioglitazone Hcl	61	18
Chlorthalidone	Chlorthalidone	59	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	15
Hydroxyzine Hcl	Hydroxyzine Hcl	51	17
Bupropion Xl	Bupropion Hcl	50	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	12
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	14
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Xarelto	Rivaroxaban	45	14
Solifenacin Succinate	Solifenacin Succinate	42	13
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Carvedilol	Carvedilol	40	13
Fenofibrate	Fenofibrate	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Alprazolam	Alprazolam	34	suppressed
Lovastatin	Lovastatin	32	suppressed
Nystatin	Nystatin	32	22
Fenofibrate	Fenofibrate,micronized	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Ozempic	Semaglutide	30	suppressed
Amoxicillin	Amoxicillin	28	16
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Glipizide	Glipizide	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Celecoxib	Celecoxib	22	13
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Ondansetron Odt	Ondansetron	22	13
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Zenpep	Lipase/Protease/Amylase	21	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Primidone	Primidone	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ketoconazole	Ketoconazole	16	13
Synthroid	Levothyroxine Sodium	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error